Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: INDICATIONS AND USAGE TOBREX ® (tobramycin ophthalmic ointment) 0.3 % is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria. US FDA label
Kidney dosing: Tobramycin (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Eye drops or ointment: same dose at any kidney function; the label gives no kidney adjustment (topical use).
- CrCl 30–59 mL/min
- Eye drops or ointment: same dose at any kidney function; the label gives no kidney adjustment (topical use).
- CrCl 15–29 mL/min
- Eye drops or ointment: same dose at any kidney function; the label gives no kidney adjustment (topical use).
- CrCl <15 mL/min (not on dialysis)
- Eye drops or ointment: same dose at any kidney function; the label gives no kidney adjustment (topical use).
- Hemodialysis (intermittent)
- Eye drops or ointment: same dose at any kidney function; the label gives no kidney adjustment (topical use).
- Peritoneal dialysis
- Eye drops or ointment: same dose at any kidney function; the label gives no kidney adjustment (topical use).
- CRRT
- Eye drops or ointment: same dose at any kidney function; the label gives no kidney adjustment (topical use).
- Dialyzable? Not relevant for ophthalmic use.
- Monitoring Clinical response of the eye infection; hypersensitivity. The label notes nephrotoxicity and ototoxicity with systemic aminoglycosides, not with eye use.
From the Tobramycin monograph (renalcarematters.com, reviewed).
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per ml ophthalmic suspension: 5 mg/3 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Loteprednol + Tobramycin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
ZyletLoteprednol Etabonate/Tobramycin | 5 mg/ 3 mg per mL (0.5% w/v / 0.3% w/v) Ophthalmic Suspension (Eye Drops)White 7.5 mL (net content: 5 mL) LDPE bottle with linear LDPE tip and polyethylene cap (Box of 1's) | Rx | Bausch & Lomb IncorporatedUSA | Bausch and Lomb Philippines Inc. | DR-XY36685 | Sep 23, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .